Receptos: “Classic” Failed Short Set-up
A reader asked for my technical take on biotechnology company, Receptos (RCPT): Two weeks ago, I wrote on RealMoneyPro, the subscription side of the TheStreet.com where I am a regular contributor, that a close in lower candle range below the horizontal support line in the $140.00 area was a speculative short entry point. I noted… Read More »